Short-term outcomes of infants of substance-using mothers admitted to neonatal intensive care units in New South Wales and the Australian Capital Territory

Journal of Paediatrics and Child Health

Volumn 43, Issue 3, 2007, Pages 127-133

  Abdel Latif, Mohamed E ^a,b   Bajuk, Barbara ^c   Lui, Kei ^a,b   Oei, Julee ^a,b  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Drugs of dependency; Infant outcome; Neonatal intensive care; Pregnancy

Indexed keywords

METHADONE; OPIATE; STEROID;

ADULT; ANTEPARTUM HEMORRHAGE; ARTICLE; CHORIOAMNIONITIS; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HIGH RISK INFANT; HUMAN; INCIDENCE; MALE; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; OPIATE ADDICTION; OUTCOME ASSESSMENT; PREGNANCY; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RURAL AREA; SUBSTANCE ABUSE; URBAN AREA;

ADULT; AUSTRALIAN CAPITAL TERRITORY; HUMANS; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; MOTHERS; NEW SOUTH WALES; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS;

EID: 33846838865     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2007.01031.x     Document Type: Article

References (33)

1. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Summary of Findings from the 2000 National Household Survey on Drug Abuse. Washington, DC: Department of Health and Human Services, 2001.
2. Craig F, Oei J, Kent-Biggs J, Lui K. Drug dependency in pregnancy - a statewide survey of maternity hospitals in NSW. Proceedings of the 9th Annual Congress of the Perinatal Society of Australia and New Zealand 2004, Adelaide, Australia: p. 32.
3. Australian Institute of Health and Welfare. Statistics on Drug Use in Australia. AIHW Cat. No. PHE 62. Canberra: AIHW (Drug Statistics Series No. 15). Available from: http://www.aihw.gov.au/publications/phe/sdua04/sdua04.pdf [updated July 29 2005, cited May 26 2006].
4. Hulse GK, Milne E, English DR, Holman CDJ. Assessing the relationship between maternal opiate use and antepartum haemorrhage. Addiction 1998; 93: 1553-8.
5. Behnke M, Eyler FD. The consequences of prenatal substance use for the developing fetus, newborn, and young child. Int. J. Addict. 1993; 28: 1341-91.
6. Lifschitz MH, Wilson GS, O'Brian Smith E et al. Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 1985; 75: 269-74.
7. Coles CD, Platzman KA. Behavioral development in children prenatally exposed to drugs and alcohol. Int. J. Addict. 1993; 28: 1393-433.
8. Van Baar AL, Soepatmi S, Gunning WB et al. Development after prenatal exposure to cocaine, heroin and methadone. Acta Paediatr. Suppl. 1994; 404: 40-6.
9. Bajuk B. Validation of the neonatal intensive care units' data collection. Proceedings of the 5th Annual Congress of the Perinatal Society of Australia and New Zealand 2001, Canberra, Australia: p. 55.
10. Abdel-Latif ME, Bajuk B, Oei J, Vincent T, Sutton L, Lui K; NICUS Group. Does rural or urban residence make a difference to neonatal outcome in premature birth? A regional study in Australia. Arch. Dis. Child Fetal Neonatal Ed. 2006; 91: F251-6. Epub 2006 Jan 20.
11. Abs.gov.au [homepage on the Internet]. Demography, Australia - 2002. Sydney: Australian Bureau of Statistics, 2004. Available from: http://www.abs.gov.au [updated 5 May 2004, cited 6 May 2004].
12. Clarke D, Bladwell W. Neonatal and Paediatric Emergency Transport Services (NETS) teams, are they always available? Proceedings of the 8th Annual Congress of the Perinatal Society of Australia and New Zealand 2004, Sydney, Australia: p. 64.
13. el Sohly MA, Stanford DF, Murphy TP et al. Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium. J. Anal Toxicol. 1999; 23: 436-45.
14. Lester BM, el Sohly MA, Wright LL et al. The maternal lifestyle study: drug use by meconium toxicology and maternal self-report. Pediatrics 2001; 107: 309-17.
15. Beeby PJ, Bhutap T, Taylor LK. New South Wales population-based birthweight percentile charts. J. Paediatr. Child Health 1996; 32: 512-18.
16. Public Health Division. The Health of the People of New South Wales-Report of the Chief Health Officer. Sydney: NSW Department of Health, 2002.
17. Commonwealth Department of Health and Aged Care and the National Key Centre for Social Applications of Geographical Information Systems (GISCA). Accessibility-Remoteness Index of Australia, Occasional Papers Series No. 5. Canberra: Department of Health and Aged Care, 1999.
18. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley, 1989.
19. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998; 316: 1236-8.
20. Eyler F, Behnke M, Garvan CW, Woods NS, Wobie K, Conlon M. Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure. Neurotoxicol. Teratol. 2001; 23: 399-411.
21. Smith L, Yonekura ML, Wallace T, Berman N, Kuo J, Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J. Dev. Behav. Pediatr. 2003; 24: 17-23.
22. Doberczak TM, Thornton JC, Bernstein J et al. Impact of maternal drug dependency on birth weight and head circumference of offspring. Am. J. Dis. Child. 1987; 141: 1163-7.
23. Soepatmi S. Developmental outcomes of children of mothers dependent on heroin or heroin/methadone during pregnancy. Acta Paediatr. Suppl. 1994; 404: 36-9.
24. Ramsey PS, Lieman JM, Brumfield CG, Carlo W. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am. J. Obstet. Gynecol. 2005; 192: 1162-6.
25. Vigneswaren R. Infection and preterm birth: evidence of a common causal relationship with bronchopulmonary dysplasia and cerebral palsy. J. Paediatr. Child Health 2000; 36: 293-6.
26. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum. Dev. 1998; 53: 81-94.
27. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann. Neurol. 1998; 44: 665-75.
28. Mooney EE, Boggess KA, Herbert WN, Layfield LJ. Placental pathology in patients using cocaine: an observational study. Obstet Gynecol. 1998; 91: 925-9.
29. Bauer C, Shankaran S, Bada H et al. The maternal lifestyle study: drug exposure during pregnancy and short-term maternal outcomes. Am. J. Obstet Gynecol. 2002; 186: 487-95.
30. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug dependant mothers. Pediatrics 2006; 117: e1163-9.
31. Bar-Oz B, Klein J, Karaskov T et al. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch. Dis. Child Fetal Neonatal Ed. 2003; 88: F98-100.
32. Armstrong M, Gonzales Osejo V, Lieberman L, Carpenter D, Pantoja P, Escobar G. Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. J. Perinatol. 2003; 23: 3-9.
33. El-Mohandes A, Herman A, El-Khorazaty MN, Katta PS, White D, Grylack L. Prenatal care reduces the impact of illicit drug use on perinatal outcomes. J. Perinatol. 2003; 23: 354-60.